$2.50
2.48% today
Nasdaq, Apr 04, 08:52 pm CET
ISIN
VGG2161P1080
Symbol
SXTC
Sector
Industry

China Sxt Pharmaceuticals, Inc. Stock price

$2.44
-2.06 45.79% 1M
-3.42 58.37% 6M
-1.63 39.98% YTD
-11.16 82.06% 1Y
-49.08 95.26% 3Y
-305.00 99.21% 5Y
-4,589.56 99.95% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.13 5.07%
ISIN
VGG2161P1080
Symbol
SXTC
Sector
Industry

Key metrics

Market capitalization $33.58m
Enterprise Value $17.50m
P/E (TTM) P/E ratio 0.89
EV/Sales (TTM) EV/Sales 9.62
P/S ratio (TTM) P/S ratio 18.45
P/B ratio (TTM) P/B ratio 0.63
Revenue growth (TTM) Revenue growth 6.78%
Revenue (TTM) Revenue $1.82m
EBIT (operating result TTM) EBIT $-372.60k
EPS (TTM) EPS $2.73
Short interest 6.70%
Show more

Is China Sxt Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Financial data from China Sxt Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Sep '24
+/-
%
1.82 1.82
7% 7%
100%
- Direct Costs 1.42 1.42
20% 20%
78%
0.40 0.40
23% 23%
22%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
-0.20 -0.20
99% 99%
-11%
- Depreciation and Amortization 0.17 0.17
29% 29%
9%
EBIT (Operating Income) EBIT -0.37 -0.37
97% 97%
-20%
Net Profit 5.80 5.80
141% 141%
319%

In millions USD.

Don't miss a Thing! We will send you all news about China Sxt Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

China Sxt Pharmaceuticals, Inc. Stock News

Neutral
GlobeNewsWire
18 days ago
TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous ...
Neutral
GlobeNewsWire
about one month ago
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homo...
Neutral
GlobeNewsWire
6 months ago
Jiangsu, China, , Oct. 07, 2024 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on October 3, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1...

Company Profile

China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces (TCMP). Its product categories includes directly-oral, after-soaking-oral, fine, and regular TCMP. It distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.

Head office Virgin Islands, British
CEO Sze Zhou
Employees 75
Founded 2005
Website www.sxtchina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today